Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). (Q42937632)
Jump to navigation
Jump to search
scientific article published on 12 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). |
scientific article published on 12 August 2010 |
Statements
1 reference
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). (English)
1 reference
Narikazu Boku
1 reference
Ichinosuke Hyodo
1 reference
Kei Muro
1 reference
Yasuhiro Shimada
1 reference
Akihito Tsuji
1 reference
Shinichi Sameshima
1 reference
Hideo Baba
1 reference
Taroh Satoh
1 reference
Tadamichi Denda
1 reference
Kenji Ina
1 reference
Tomohiro Nishina
1 reference
Kensei Yamaguchi
1 reference
Hiroya Takiuchi
1 reference
Taito Esaki
1 reference
Shinya Tokunaga
1 reference
Hiroyuki Kuwano
1 reference
Yoshito Komatsu
1 reference
Masahiko Watanabe
1 reference
Satoshi Morita
1 reference
Kenichi Sugihara
1 reference
12 August 2010
1 reference
1 reference
Identifiers
1 reference